HCC Cohort (n = 20) | Mean overall survival (months) (standard error) | Median overall survival (months) (95% CI) | pvalue (Log-Rank test) |
---|---|---|---|
CTC per 7.5Â mL | Â | Â | Â |
  < 1.0 (n = 12) | 10.96 (1.95) | 11.29 (2,69, 16.06) |  |
  1.0 (n = 8) | 8.49 (3.63) | 2.76 (0.72, 15.54) | 0.6179 |
  <2.0 (n = 13) | 10.37 (1.89) | 10.32 (3.25, 12.91) | 0.8021 |
  ≥2.0 (n = 7) | 9.23 (4.11) | 2.20 (0.72, 15.54) | 0.8510 |
  <3.0 (n = 14) | 9.74 (1.86) | 9.45 (2.69, 12.91) |  |
  ≥3.0 (n = 6) | 10.50 (4.62) | 8.26 (0.72, 29.14) |  |
Median AFP (ng/mL) | Â | Â | Â |
  <400 (n = 10) | 11.20 (2.29) | 11.32 (2.69, 16.07) | 0.4058 |
  ≥400 (n = 10) | 8.73 (2.92) | 5.39 (0.72, 14.32) |  |
Macrovessel invasion | Â | Â | Â |
  No (n = 7) | 10.12 (2.48) | 10.32 (2.69, 12.91) | 0.7493 |
  Yes (n = 13) | 10.45 (2.82) | 8.58 (1.58, 15.54) |  |
Child Pugh score (%) | Â | Â | Â |
  A (n = 14) | 10.69 (1.87) | 11.32 (2.20, 15.54) |  |
  B (n = 5) | 9.29 (5.39) | 3.25 (0.72, 29.14) | 0.7181 |
  C (n = 1) | I |  |  |
Etiology of liver disease (%) | Â | Â | Â |
  HBV (n = 5) | 10.28 (3.83) | 8.58 (2.20, 21.85) |  |
  HCV (n = 9) | 10.41 (1.96) | 12.62 (1.91, 15.54) | 0.9324 |
  HBV + HCV (n = 2) | I | I |  |
  ETOH (n = 1) | I | I |  |
  NAFLD (n = 2) | I | I |  |
  Unknown (n = 1) | I | I |  |